News

Dallas-based Dean Omar Branham Shirley is handling another talcum powder trial against Johnson & Johnson, which began on ...
Johnson & Johnson (NYSE:JNJ) is one of the 10 undervalued blue chip stocks analysts recommend for smart investing. On June 18, Dean Omar Branham Shirley, LLP, a Dallas, Texas-based law firm ...
As previously reported HERE in the Asbestos Case Tracker, a Louisiana jury on May 7 returned a plaintiff’s verdict against talc manufacturer Johnson & Johnson and talc supplier Pecos River Talc LLC.
The verdict was awarded to Janice Paluzzi, an 84-year-old Massachusetts woman who developed mesothelioma, a rare and aggressive cancer linked to asbestos exposure.
Johnson & Johnson Hit With $8M Verdict in Massachusetts Mesothelioma Talc Lawsuit Jury concludes J&J concealed the danger of its asbestos-laced talcum powder that caused woman’s cancer ...
Johnson & Johnson convinced a U.S. appeals court on Tuesday to reject a bid from generic drugmakers Teva and Viatris to ...
Johnson & Johnson moved to dismiss an amended, proposed class action alleging the company engaged in fraudulent transfers to cheat talc litigation plaintiffs of recoveries.
Wednesday’s verdict, which was all compensatory damages, is the first in a talc trial against Johnson & Johnson in Boston.
Johnson & Johnson has asked a federal judge in Central California for a judgment as a matter of law to throw out a jury's ...